主页 文献库文献详情
PMID: 23708519 已发表 · ppublish 英语

Caloric restriction augments radiation efficacy in breast cancer.

Cell cycle (Georgetown, Tex.) ·第 12 卷 ·第 12 期 ·2014-02-04

Saleh Anthony D, Simone Brittany A, Palazzo Juan, Savage Jason E, Sano Yuri, Dan Tu, Jin Lianjin, Champ Colin E, Zhao Shuping, Lim Meng, Sotgia Frederica, Camphausen Kevin, Pestell Richard G, Mitchell James B, Lisanti Michael P, Simone Nicole L

摘要

Dietary modification such as caloric restriction (CR) has been shown to decrease tumor initiation and progression. We sought to determine if nutrient restriction could be used as a novel therapeutic intervention to enhance cytotoxic therapies such as radiation (IR) and alter the molecular profile of triple-negative breast cancer (TNBC), which displays a poor prognosis. In two murine models of TNBC, significant tumor regression is noted with IR or diet modification, and a greater regression is observed combining diet modification with IR. Two methods of diet modification were compared, and it was found that a daily 30% reduction in total calories provided more significant tumor regression than alternate day feeding. At the molecular level, tumors treated with CR and IR showed less proliferation and more apoptosis. cDNA array analysis demonstrated the IGF-1R pathway plays a key role in achieving this physiologic response, and multiple members of the IGF-1R pathway including IGF-1R, IRS, PIK3ca and mTOR were found to be downregulated. The innovative use of CR as a novel therapeutic option has the potential to change the biology of tumors and enhance the opportunity for clinical benefit in the treatment of patients with TNBC.

关键词
IGF breast cancer caloric restriction cytotoxic therapy radiation tumor regression
文献信息
期刊
Cell cycle (Georgetown, Tex.)
期刊简称
Cell Cycle
发表日期
2014-02-04
收录日期
2013-07-01
更新日期
2016-10-19
语言
英语
国家/地区
United States
NLM ID
101137841
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com